stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Aktis Oncology IncAKTS
$14.598.41%-1.34

Aktis Oncology Inc (AKTS)

Date: 2026-11-02 16:00O: 16.01H: 16.01L: 13.96C: 14.59Vol: 898.2k
Precedente Chiudi:
$15.93
Aprire:
$16.01
Volume 24 ore:
898,181
Volume relativo:
2.78
Capitalizzazione di mercato:
$811.49M
Reddito:
$7.48M
Utile/perdita netta:
-$60.50M
Rapporto P/E:
-
EPS:
-$1.13
Flusso di cassa netto:
-$52.28M
1W Prestazione:
-11.31%
1M Prestazione:
-21.22%
6M Prestazione:
-24.87%
1Y Prestazione:
+39,120%
Intervallo 1D:
$0.00$0.00
Intervallo di 1 settimana:
$13.96$17.33
Portata 52W:
$0.033$34.19

Profilo aziendale di Aktis Oncology Inc (AKTS)

Nome
Aktis Oncology Inc
Settore
Healthcare
Industria
Biotechnology
Telefono
978-237-4380
Indirizzo
17 DRYDOCK AVENUE, BOSTON, NC, USA
Dipendente
79
Prossima data di guadagno
2026-11-12
Ultimi documenti SEC
SEC
Discussioni di AKTS su X
X

 

Cap. di mercato

 

Reddito

 

Reddito netto

 

Flusso di cassa

 

EPS

 

Aktis Oncology Inc Azioni (AKTS) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-09-09IniziatoOppenheimerOutperform
2026-08-19IniziatoBMO Capital MarketsOutperform
2026-08-19IniziatoWedbushOutperform
2026-06-16IniziatoRaymond JamesStrong Buy

Aktis Oncology Inc Azioni (AKTS) Dati Finanziari

PeriodoAndamentoFY 2023FY 2022FY 2021FY 2020FY 2019
Data di fine periodo-2022-06-302021-06-302020-06-302019-06-30
Revenue USD (M)27.1215.356.621.791.44
Cost of revenue USD (M)30.2419.4910.652.411.01
Gross profit USD (M)-3.12-4.14-4.03-0.620.43
Research and development USD (M)33.2435.7124.0820.5219.25
Operating expenses USD (M)62.9556.4237.3631.4128.00
Operating income USD (M)-66.07-60.56-41.39-32.04-27.57
Income before tax USD (M)-66.0115.35-44.161.791.44
Income tax expense USD (M)-2.45-1.83---
Net income USD (M)-63.56-59.19-44.16-36.14-29.25
Basic EPS USD/shares-1.00-1.09---
Diluted EPS USD/shares-1.00-1.09---
Basic weighted shares shares (M)63.6254.02---
Diluted weighted shares shares (M)63.6254.02---
Selling, general and administrative USD (M)29.71----

Aktis Oncology Inc Azioni (AKTS) insider trading

  • Czibere AkosSep 23 '26
    Chief Medical Officer
    Transazione
    Option Exercise
    Costo
    $4.95
    #Azioni
    12,500
    Valore ($)
    61,875
    #Azioni Totale
    12,500
  • Czibere AkosSep 23 '26
    Chief Medical Officer
    Transazione
    Sale
    Costo
    $20.69
    #Azioni
    12,500
    Valore ($)
    258,621
    #Azioni Totale
    0
  • Akos CzibereSep 23 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $22.11
    #Azioni
    25,000
    Valore ($)
    552,750
    #Azioni Totale
    0
  • Herrmann KenJul 20 '26
    Director
    Transazione
    Sale
    Costo
    $24.56
    #Azioni
    4,856
    Valore ($)
    119,274
    #Azioni Totale
    0
  • KEN HERRMANNJul 20 '26
    Director
    Transazione
    Proposed Sale
    Costo
    $24.56
    #Azioni
    4,856
    Valore ($)
    119,275
    #Azioni Totale
    0
  • Herrmann KenJul 20 '26
    Director
    Transazione
    Option Exercise
    Costo
    $0.59
    #Azioni
    4,856
    Valore ($)
    2,859
    #Azioni Totale
    4,856
  • KEN HERRMANNJul 17 '26
    Director
    Transazione
    Proposed Sale
    Costo
    $25.21
    #Azioni
    3,065
    Valore ($)
    77,259
    #Azioni Totale
    0
  • Herrmann KenJul 17 '26
    Director
    Transazione
    Sale
    Costo
    $25.21
    #Azioni
    3,065
    Valore ($)
    77,259
    #Azioni Totale
    0
  • Herrmann KenJul 17 '26
    Director
    Transazione
    Option Exercise
    Costo
    $0.08
    #Azioni
    3,065
    Valore ($)
    245
    #Azioni Totale
    3,065
  • Chief Operating Officer
    Transazione
    Sale
    Costo
    $27.75
    #Azioni
    50,000
    Valore ($)
    1,387,558
    #Azioni Totale
    0
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
Czibere AkosChief Medical OfficerSep 23 '26Option Exercise$4.9512,50061,87512,500
Czibere AkosChief Medical OfficerSep 23 '26Sale$20.6912,500258,6210
Akos CzibereOfficerSep 23 '26Proposed Sale$22.1125,000552,7500
Herrmann KenDirectorJul 20 '26Sale$24.564,856119,2740
KEN HERRMANNDirectorJul 20 '26Proposed Sale$24.564,856119,2750
Herrmann KenDirectorJul 20 '26Option Exercise$0.594,8562,8594,856
KEN HERRMANNDirectorJul 17 '26Proposed Sale$25.213,06577,2590
Herrmann KenDirectorJul 17 '26Sale$25.213,06577,2590
Herrmann KenDirectorJul 17 '26Option Exercise$0.083,0652453,065
Ron-Bigger ShulamitChief Operating OfficerJul 08 '26Sale$27.7550,0001,387,5580

Aktis Oncology Inc Borsa (AKTS) Ultime notizie

Oct 23, 2026
Oct 23, 2026
Oct 20, 2026
Oct 20, 2026
Oct 14, 2026
Oct 14, 2026
Oct 10, 2026
Oct 10, 2026
Sep 27, 2026
Sep 27, 2026
Sep 26, 2026
Sep 26, 2026
Sep 26, 2026
Sep 26, 2026
Sep 26, 2026
Sep 26, 2026
Sep 24, 2026
Sep 24, 2026
Sep 23, 2026
Sep 23, 2026
Sep 23, 2026
Sep 23, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 08, 2026
Sep 08, 2026
Sep 03, 2026
Sep 03, 2026
Aug 31, 2026
Aug 31, 2026
Aug 29, 2026
Aug 29, 2026
Aug 28, 2026
Aug 28, 2026
Aug 22, 2026
Aug 22, 2026
Aug 21, 2026
Aug 21, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 15, 2026
Aug 15, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 08, 2026
Aug 08, 2026

Simile a AKTS